Seed fixity in the prostate/periprostatic region following brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 1, 2000, Pages 215-220

  Merrick, Gregory S ^a,b   Butler, Wayne M ^a   Dorsey, Anthony T ^a   Lief, Jonathan H ^a,c   Benson, Mark L ^a  

^a WHEELING HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c WHEELING JESUIT UNIVERSITY   (United States)

Author keywords

CT volume; Dosimetry; Prostate brachytherapy; Quality

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; IODINE 125; PALLADIUM;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; DOSIMETRY; HUMAN; IMPLANT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; X RAY;

AGED; BRACHYTHERAPY; FOREIGN-BODY MIGRATION; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PALLADIUM; PROSTATIC NEOPLASMS; PULMONARY EMBOLISM; RADIOISOTOPES;

EID: 0033985446     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00405-8     Document Type: Article

References (22)

1. Willins J., Wallner K. CT based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 39:1997;347-353.
2. Wallner K., Roy J., Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 32:1995;1465-1471.
3. Willins J., Wallner K. Time-dependant changes in CT-based dosimetry for I-125 prostate brachytherapy. Rad Onc Invest. 6:1998;157-160.
4. Merrick G.S., Butler W.M., Dorsey A.T., et al. Prostatic conformal brachytherapy I-125/Pd-103 post-operative dosimetric analysis . Rad Onc Invest. 5:1997;305-313.
5. Merrick G.S., Butler W.M., Dorsey A.T., et al. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided prostatic conformal brachytherapy. Rad Onc Invest. 6:1998;182-190.
6. Merrick GS, Butler WM, Dorsey AT; et al. The influence of prophylactic dexamethasone on edema following prostate brachytherapy. Tech Urol, in press.
7. Merrick G.S., Butler W.M., Dorsey A.T., et al. Potential role of various dosimetric quality indicators in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 44:1999;717-724.
8. Merrick G.S., Butler W.M., Dorsey A.T., et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 43:1999;1021-1027.
9. Merrick G.S., Butler W.M., Dorsey A.T., et al. The dependance of prostate post-implant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys. 44:1999;1111-1117.
10. Prestidge B.R., Bice W.S., Kiefer E.T., et al. Timing of computed tomography based post-implant assessment following permanent transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;1111-1115.
11. Moerland M.A., Wijrdeman H.K., Beersma R., et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic imaging. Int J Radiat Oncol Biol Phys. 37:1997;927-933.
12. Waterman F.M., Yue N., Corn B.W., et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry An analysis based serial CT acquisitions . Int J Radiat Oncol Biol Phys. 41:1998;1069-1077.
13. Stock R.G., Stone N.N., Tabert A., et al. A dose response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 41:1998;101-108.
14. Sommerkamp H., Rupprecht M., Wannenmacher M. Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. Int J Radiat Oncol Biol Phys. 14:1988;389-392.
15. Kumar P.P., Good R.R. Vicryl carrier for I-125 seeds percutaneous transperineal insertion . Radiology. 159:1986;276.
16. Tapen E.M., Blasko J.C., Grimm P.D., et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 42:1998;1063-1067.
17. Grimm P.D., Blasko J., Ragde H., et al. Migration of iodine-125 and palladium-103 seeds to the lung after transperineal brachytherapy for prostate cancer. Endocurie/Hypertherm Oncol. 9:1993;50.
18. Nag S., Vivekanandam S., Martinez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 39:1997;667-670.
19. Nag S., Scaperoth D.D., Badalament R., et al. Transperineal palladium 103 prostate brachytherapy analysis of morbidity and seed migration . Urology. 45:1995;87-92.
20. Steinfeld A.D., Donahue B.R., Plaine L. Pulmonary embolization of iodine-125 seeds following prostate implantation. Urology. 37:1991;149-150.
21. Merrick G.S., Butler W.M., Farthing W.H., et al. The impact of Gleason score accuracy as a criterion for prostate brachytherapy patient selection. J Brachytherapy Int. 14:1998;113-121.
22. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources recommendations of the AAPM Radiation Therapy Committee Task Group No . 43: Med Phys. 22:1995;209-234.